| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PATX | 9.41 | 0.45 | +5.00% |
| Tradr 2X Long PATH Daily ETF (PATX) | |||
| BBC | 45.21 | 0.33 | +0.73% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
| HERZ | 15.25 | N/A | N/A |
| Herzfeld Credit Income Fund Inc. | |||
| LDRC | 24.65 | -0.03 | -0.12% |
| iShares iBonds 1-5 Year Corporate Ladder ETF | |||
| RQI | 11.79 | -0.04 | -0.34% |
| COHEN & STEERS QUALITY Income REALTY FUND | |||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RQI | 11.79 | -0.04 | -0.34% |
| COHEN & STEERS QUALITY Income REALTY FUND | |||
| LDRC | 24.65 | -0.03 | -0.12% |
| iShares iBonds 1-5 Year Corporate Ladder ETF | |||
| HERZ | 15.25 | N/A | N/A |
| Herzfeld Credit Income Fund | |||
| BBC | 45.21 | 0.33 | +0.73% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
| PATX | 9.41 | 0.45 | +5.00% |
| Tradr 2X Long PATH Daily ETF (PATX) | |||
A.I.dvisor indicates that over the last year, EPSB has been loosely correlated with IJR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if EPSB jumps, then IJR could also see price increases.
| Ticker / NAME | Correlation To EPSB | 1D Price Change % | ||
|---|---|---|---|---|
| EPSB | 100% | -0.11% | ||
| IJR - EPSB | 44% Loosely correlated | -0.37% | ||
| VB - EPSB | 44% Loosely correlated | -0.44% | ||
| IWM - EPSB | 43% Loosely correlated | -0.68% | ||
| VTWO - EPSB | 43% Loosely correlated | -0.67% | ||
| SCHA - EPSB | 41% Loosely correlated | -0.48% |
EPSB moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 2 of 2 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EPSB as a result. In 8 of 13 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for EPSB just turned positive on November 09, 2026. Looking at past instances where EPSB's MACD turned positive, the stock continued to rise in 8 of 11 cases over the following month. The odds of a continued upward trend are 73%.
The 10-day moving average for EPSB crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +4.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where EPSB advanced for three days, in 5 of 10 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
EPSB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for EPSB moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 7 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EPSB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for EPSB entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.